Moleculin Biotech Files 8-K with Corporate Updates
Ticker: MBRX · Form: 8-K · Filed: Jul 17, 2025 · CIK: 1659617
Sentiment: neutral
Topics: corporate-filing, financials, disclosure
Related Tickers: MBRX
TL;DR
Moleculin Biotech (MBRX) filed an 8-K on 7/17 detailing corporate info & financials.
AI Summary
Moleculin Biotech, Inc. filed an 8-K on July 17, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 5300 Memorial Drive, Suite 950, Houston, TX 77007, with a phone number of (713) 300-5160. The company is incorporated in Delaware and operates within the Pharmaceutical Preparations industry.
Why It Matters
This filing provides essential corporate information and disclosures for investors and stakeholders, including financial statement details and regulatory compliance updates.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse events.
Key Numbers
- 713-300-5160 — Registrant's telephone number (Contact information for Moleculin Biotech, Inc.)
Key Players & Entities
- Moleculin Biotech, Inc. (company) — Registrant
- 5300 Memorial Drive, Suite 950, Houston, TX 77007 (location) — Principal executive offices
- July 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 47-4671997 (identifier) — I.R.S. Employer Identification No.
FAQ
What specific event triggered this 8-K filing?
The filing indicates it is for a Regulation FD Disclosure and Financial Statements and Exhibits, with the earliest event reported on July 17, 2025.
Where are Moleculin Biotech's principal executive offices located?
The principal executive offices are located at 5300 Memorial Drive, Suite 950, Houston, TX 77007.
What is the company's fiscal year end?
The company's fiscal year ends on December 31 (1231).
In which state was Moleculin Biotech, Inc. incorporated?
Moleculin Biotech, Inc. was incorporated in Delaware.
What is the SIC code for Moleculin Biotech, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding Moleculin Biotech, Inc. (MBRX).